Fc-Silenced CD89 × EGFR Bispecific Antibodies Promote Neutrophil and Macrophage Antitumor Activity
Antibodies · 29.07.2026 · 15 (4) · 66
DOI: 10.3390/antib15040066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibodies, online erschienen am 29.07.2026. Verfasst von Felix Meiser und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, 64287 Darmstadt, Germany. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: CD89 (FcaRI), the receptor for immunoglobulin A (IgA), is expressed on myeloid cells, including neutrophils, monocytes, and macrophages. It is known to mediate potent effector functions against tumor cells, but the clinical development of IgA-based therapeutics is hindered by manufacturing challenges and IgA’s short plasma half-life.
Methods
Using yeast display, we generated EGFR × CD89 bispecific common light chain antibodies and investigated their biophysical properties, neutrophil-mediated cytotoxicity and macrophage phagocytosis in vitro.
Results
CD89-targeting constructs induced potent neutrophil cytotoxicity and macrophage phagocytosis in vitro. A symmetric 2 + 2 IgG1 Fc-silenced variant showed the most consistent potency across neutrophil and macrophage effector functions. Fc silencing enhanced neutrophil ADCC and did not induce detectable neutrophil or PBMC fratricide under the conditions tested, suggesting a limited propensity for off-target immune cell killing.
Conclusions
These findings support further preclinical evaluation of CD89-targeting bispecific antibodies and indicate that Fc silencing may differentially shape neutrophil- and macrophage-mediated antitumor activity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, 64287 Darmstadt, Germany.
- Division of Stem Cell Transplantation and Cellular Immunotherapy, Christian-Albrechts-University, 24105 Kiel, Germany.
- Centre for Synthetic Biology, Technical University of Darmstadt, 64287 Darmstadt, Germany.
ORCID-Profile: Felix Meiser, Thomas Valerius, Harald Kolmar
Zitieren
APA
Meiser, F., Harwardt, J., Hahn, C., Lustig, M., Valerius, T., & Kolmar, H. (2026). Fc-Silenced CD89 × EGFR Bispecific Antibodies Promote Neutrophil and Macrophage Antitumor Activity. Antibodies, 15(4), 66. https://doi.org/10.3390/antib15040066
Vancouver
Meiser F, Harwardt J, Hahn C, Lustig M, Valerius T, Kolmar H. Fc-Silenced CD89 × EGFR Bispecific Antibodies Promote Neutrophil and Macrophage Antitumor Activity. Antibodies. 2026;15(4):66. doi:10.3390/antib15040066
BibTeX
@article{Meiser2026,
author = {Meiser, Felix and Harwardt, Julia and Hahn, Christoph and Lustig, Marta and Valerius, Thomas and Kolmar, Harald},
title = {Fc-Silenced CD89 × EGFR Bispecific Antibodies Promote Neutrophil and Macrophage Antitumor Activity},
journal = {Antibodies},
year = {2026},
volume = {15},
number = {4},
pages = {66},
doi = {10.3390/antib15040066}
}
EUVIMED